SCHOTT Pharma AG & Co. KGaA | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases SCHOTT Pharma AG & Co. KGaA

Home
Companies
SCHOTT Pharma AG & Co. KGaA

BRIEF

published on 12/04/2025 at 19:15, 9 hours 17 minutes ago

SCHOTT Pharma Reports Preliminary 2025 Financial Results

EBITDA Margin Mid-term Guidance Drug Delivery Systems Preliminary Results 2025 Financial Forecast 2026
PRESS RELEASE

published on 12/04/2025 at 19:10, 9 hours 22 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
SCHOTT Pharma's preliminary results for fiscal year 2025 show revenue growth and increased EBITDA margin. Outlook for FY 2026 includes moderate revenue growth and mid-term guidance updates towards 30% EBITDA margin by 2029

Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Mid-term Guidance
BRIEF

published on 12/04/2025 at 18:58, 9 hours 34 minutes ago

SCHOTT Pharma Revises 2026 Fiscal Outlook and Mid-Term Guidance

Revenue Growth EBITDA Margin SCHOTT Pharma Mid-term Guidance 2026 Outlook
PRESS RELEASE

published on 12/04/2025 at 18:53, 9 hours 39 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
SCHOTT Pharma AG & Co. KGaA issues fiscal year 2026 outlook and updates mid-term guidance, projecting revenue growth of 2-5% and EBITDA margin around 27%. Market expectations differ

Revenue Growth Financial Guidance EBITDA Margin SCHOTT Pharma Fiscal Year 2026
BRIEF

published on 11/05/2025 at 18:24, 29 days 10 hours ago

Leadership Transition at SCHOTT Pharma: Christian Mias Appointed CEO

SCHOTT Pharma Leadership Transition Executive Appointment Pharmaceutical Growth Christian Mias
PRESS RELEASE

published on 11/05/2025 at 18:19, 29 days 10 hours ago

SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma
Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader

Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF

published on 11/05/2025 at 18:01, 29 days 10 hours ago

Christian Mias Appointed as New CEO of SCHOTT Pharma

CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE

published on 11/05/2025 at 17:56, 29 days 10 hours ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO
SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News

Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF

published on 08/12/2025 at 07:05, 3 months 23 days ago

SCHOTT Pharma Reports Steady Q3 2025 Results

Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE

published on 08/12/2025 at 07:00, 3 months 23 days ago

SCHOTT Pharma delivers solid final third-quarter results
SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations

Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results

1 2 ... 7

Accesswire

Published on 12/05/2025 at 02:35, 1 hour 58 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 3 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 3 hours 33 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 28 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 33 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 2 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 42 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 7 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 17 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 22 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 10 hours 33 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 48 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 48 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 32 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE